Frovatriptan chemical structure

Find information on thousands of medical conditions and prescription drugs.

Frova

Frovatriptan (Frova®) is a triptan drug developed by Endo Pharmaceuticals for the treatment of migraine headaches. It is available as 2.5 mg tablets.

Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than for other triptans.

Frovatriptan is available only by prescription in the United States.

A

B

C

D

E

F

Fludrocortisone

Fluorometholone

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	Migraine headaches: how to deal with the pain What causes migraine headaches? Migraine headaches seem to be caused by changes in the amount of a chemical called serotonin (say: sair-uh-TONE-in) ... From American Family Physician, 11/1/05

	Migraine drugs Migraine symptoms improve in up to 70% of women during pregnancy. But in 4%-8% of women, migraines worsen, and as many as 16% of all migraine cases during pregnancy may be new onset. A 2002 revie From OB/GYN News, 1/15/05 by Gerald G. Briggs

	Triptans Can Prevent Menstrual Migraine Women who suffer from menstrual migraines, which can develop between 2 days before and 4 days after the onset of menses, may now find relief by taking ... From Nurse Practitioner, 9/1/04

	Two studies; Menstrual migraines: more severe but treatable Menstrually associated migraines tend to be more severe than attacks that occur at other times of the month, an observational study has shown. In addition, the intensity and duration of menstrual From OB/GYN News, 9/1/04 by Diana Mahoney

	What to do when your head aches: news, breakthroughs, and remedies to ease your pain - Good Medicine Fifty million of us are gripped by chronic headaches. Yet most of us could get relief if our pain was identified correctly. Migraines, for example, are misdiagnosed more often than not by general p From Natural Health, 1/1/04 by Shari Roan

	Elan Completes Sale of Frova to Vernalis Business Editors DUBLIN, Ireland--(BUSINESS WIRE)--May 18, 2004 Elan Corporation, plc today announced the closing of its agreement with the Vernalis ... From Business Wire, 5/18/04

	Elan Announces Agreement with Vernalis Regarding North American Rights for Frova Business Editors/Health/Medical Writers DUBLIN, Ireland--(BUSINESS WIRE)--March 30, 2004 Elan Corporation, plc today announced an agreement with ... From Business Wire, 3/30/04

	Triptan may help prevent menstrual migraine - Study of 545 Women HONOLULU -- Frovatriptan prevented menstrually associated migraine headaches in 50% of those who took a twice-daily dose during the perimenstrual period, ... From OB/GYN News, 7/15/03 by Robert Finn

Home

Contact

Resources

ebay